CryoPort Q2 2026 Earnings Call Transcript

CryoPort (NASDAQ: CYRX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary CryoPort Inc reported second-quarter 2026 revenue of $49 million, with a 15% growth in Life Science Services and a 9% increase in commercial cell and gene therapy support. The company achieved a positive adjusted EBITDA of $400,000, marking progress in their Pathway to Profitability initiative, and reaffirmed its full-year revenue guidance of $192 to $196 million. Operational highlights include the expansion of IntegriCell cryopreservation services in Houston and Liège, and the introduction of new p...